Clinical Trials on Solid Cancers

Total 56092 results

University of Wisconsin, Madison
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

Real-time Tumor Localization and Guidance for Radiotherapy Using Ultrasound (US) and Magnetic Resonance (MR)

Tumor, Solid

United States
Pfizer

Completed

Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials

Solid Tumors

United States, Taiwan, Japan, Korea, Republic of, Russian Federation, Hungary, France, Czechia, Germany, Italy, United Kingdom
Kite, A Gilead Company

Terminated

Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers

Solid Tumor

United States
University of Southern California
National Cancer Institute (NCI)

Active, not recruiting

Movement Tracking Devices to Monitor Physical Activity in Patients Undergoing Chemotherapy

Solid Neoplasm

United States
Eikon Therapeutics
Seven and Eight Biopharmaceuticals Inc

Completed

BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid Tumors

Tumor, Solid

United States
Refnot-Pharm Ltd

Completed

Effect of Refnot on Immunity in Cancer Patients (R-2)

Solid Tumor
Debiopharm International SA

Completed

Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143 (SMARTPLUS-106)

Solid Tumor

United States, Spain, France
Jiangsu HengRui Medicine Co., Ltd.

Completed

Bioequivalence Study of Famitinib Malate in Healthy Volunteers Under Fasting Condition

Solid Tumor

China
Samsung Medical Center

Completed

Study to Evaluate the Safety and Efficacy of Gefitinib, in Subjects With EFGR Amplification Refractory Solid Tumors

Solid Tumor

Korea, Republic of
AnHeart Therapeutics Inc.

Completed

A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PK

Solid Tumor

China
Glycotope GmbH

Completed

PankoMab-GEX™: Phase 1 Dose Escalation Study

Solid Tumors

Germany, Italy, Switzerland
National Cancer Centre, Singapore
National Medical Research Council (NMRC), Singapore; ASLAN Pharmaceuticals

Active, not recruiting

ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin

Solid Tumors

Singapore
Royal Marsden NHS Foundation Trust
Institute of Cancer Research, United Kingdom; Onyx Therapeutics, Inc.

Completed

Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly (ONX-0801)

Solid Tumours

United Kingdom
Tracon Pharmaceuticals Inc.

No longer available

Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial

Solid Tumors

United States
Merck Sharp & Dohme LLC

Completed

Study of MK-4166 and MK-4166 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4166-001)

Solid Tumor
Institut Claudius Regaud

Completed

Cohort Study: Modelling Toxicity Processing in Patients Treated by Immunotherapy (MOTIVATE). (MOTIVATE)

Solid Tumor

France
National University Hospital, Singapore
Karyopharm Therapeutics Inc

Completed

Phase I Study of KPT330 in Asian Patients

Solid Tumors

Singapore
Debiopharm International SA

Terminated

Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations

Solid Tumours

Korea, Republic of, United States, Taiwan, Spain, Singapore
AVEO Pharmaceuticals, Inc.

Terminated

A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols

Solid Tumors

United States, Canada, Netherlands, India, Russian Federation, Ukraine
Kyunghee University Medical Center

Unknown

Safety of the Combination of SH003 and Docetaxel in Patients With Solid Cancer

Solid Tumor
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Unknown

Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A

Solid Tumors

United States
Merck Sharp & Dohme LLC

Terminated

A Study of the Safety, Tolerability, and Efficacy of MK-8353 in Participants With Advanced Solid Tumors (MK-8353-001)

Tumor, Solid
University Health Network, Toronto

Completed

Feasibility Clinical Study of Targeted and Genome-Wide Sequencing

Solid Tumors

Canada
AstraZeneca
Parexel

Completed

A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole

Solid Tumour

United States
Samsung Medical Center

Withdrawn

Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy (RICTOR_SC)

Solid Tumor

Korea, Republic of
Daiichi Sankyo, Inc.
Medpace, Inc.

Completed

Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects

Solid Tumors

United States
Gilead Sciences

Completed

Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody

Solid Tumor

United States
AbbVie (prior sponsor, Abbott)

Completed

A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects

Solid Tumors

United States
Sanofi

Completed

Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial

Solid Tumors

Belgium, Italy, United States, Spain
Efranat Ltd.

Completed

Safety Study of EF-022 ( Modified Vitamin D Binding Protein Macrophage Activator) in Subjects With Advanced Solid Tumors

Solid Tumors

Israel
Samsung Medical Center

Completed

Study to Evaluate the Safety and Efficacy of Everolimus, in Subjects With PIK3CA Amplification, PTEN Loss and PIK3CA Mutation Refractory Solid Tumors

Solid Tumor

Korea, Republic of
M.D. Anderson Cancer Center

Completed

Trial of PBI-05204 in Advanced Cancer Patients

Solid Tumors

United States
AstraZeneca

Completed

To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers

Solid Tumours

United States
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED)

Solid Tumor
Herbert Hurwitz, MD
Novartis; Genentech, Inc.; Amgen

Completed

BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab) (BEP)

Solid Tumors

United States
AstraZeneca

Completed

To Assess the Effect of Food on the Pharmacokinetics of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Male Volunteers

Solid Tumours

United States
Herbert Hurwitz
Genentech, Inc.; Abbott

Completed

A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors

Solid Tumors

United States
Kyowa Kirin Co., Ltd.

Completed

A Study of LY2523355 in Patients With Solid Cancer (2523355-001)

Solid Tumors

Japan
Pfizer

Completed

Rollover Protocol for Prior SU011248 Protocols

Solid Tumors

United States, Australia, Italy, Greece, Sweden, Switzerland, United Kingdom, Canada, Singapore, France, Netherlands
CrystalGenomics, Inc.

Unknown

Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile

Solid Tumour

Korea, Republic of
National University Hospital, Singapore

Completed

Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype

Solid Tumor

Singapore
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients

Solid Tumor

United States
Novartis Pharmaceuticals

Terminated

Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 Inhibitor

Solid Tumors

United States
Abbott
Genentech, Inc.

Withdrawn

Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors

Solid Tumors
Tracon Pharmaceuticals Inc.

Active, not recruiting

Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer

Solid Tumor | Metastatic Cancer

United States
Metaxa Hospital

Unknown

Metaxa Hospital THromboprophylaxis Program in Oncological & Surgical Patients (MeTHOS)

Thrombosis | Solid Cancer

Greece
National Cancer Institute (NCI)

Active, not recruiting

Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer

Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | HER2-Positive Breast Carcinoma

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study to Evaluate the Safety and Tolerability of Using SHR-1210 by Advanced Solid Tumor Subjects

Breast Cancer | Solid Tumor | Gastrointestinal Cancer

China
Northwestern University
Genentech, Inc.

Completed

Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy

Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer

United States
Bristol-Myers Squibb

Completed

Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin

Breast Cancer | Solid Tumors

United States

3

Subscribe